Zeng ZM - Search Results

1

Positive association between heart dosimetry parameters and a novel cardiac biomarker, solubleST-2, in thoracic cancer chest radiation.

Zeng ZM, Xu P, Zhou S, Du HY, Jiang XL, Cai J, Huang L, Liu AW. Zeng ZM, et al. J Clin Lab Anal. 2020 Apr;34(4):e23150. doi: 10.1002/jcla.23150. Epub 2020 Jan 10. J Clin Lab Anal. 2020. PMID: 31923333 Free PMC article.

2

CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway.

Wang Y, Tu Q, Yan W, Xiao D, Zeng Z, Ouyang Y, Huang L, Cai J, Zeng X, Chen YJ, Liu A. Wang Y, et al. Biochem Biophys Res Commun. 2015 Jan 2;456(1):373-9. doi: 10.1016/j.bbrc.2014.11.090. Epub 2014 Dec 2. Biochem Biophys Res Commun. 2015. PMID: 25475726

3

Derlin-1 exhibits oncogenic activities and indicates an unfavorable prognosis in breast cancer.

Zeng J, Tian Q, Zeng Z, Cai J, Ye M, Liu Y, Liu A. Zeng J, et al. Cell Biol Int. 2020 Feb;44(2):593-602. doi: 10.1002/cbin.11259. Epub 2019 Nov 26. Cell Biol Int. 2020. PMID: 31670413

4

BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest.

Zeng ZM, Du HY, Xiong L, Zeng XL, Zhang P, Cai J, Huang L, Liu AW. Zeng ZM, et al. Among authors: zeng xl. Life Sci. 2020 Mar 1;244:117342. doi: 10.1016/j.lfs.2020.117342. Epub 2020 Jan 21. Life Sci. 2020. PMID: 31978450

5

[Management of Drug Therapy for Leptomeningeal Metastasis of Sensitive Driver Gene Positive Non-small Cell Lung Cancer].

Lu Z, Cai J, Zeng Z, Liu A. Lu Z, et al. Zhongguo Fei Ai Za Zhi. 2020 Aug 20;23(8):710-718. doi: 10.3779/j.issn.1009-3419.2020.102.18. Epub 2020 Aug 6. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32758347 Free PMC article. Chinese.

6

Osimertinib combined with bevacizumab for leptomeningeal metastasis from EGFR-mutation non-small cell lung cancer: A phase II single-arm prospective clinical trial.

Lu ZQ, Cai J, Wang X, Wei JP, Zeng ZM, Huang L, Liu AW. Lu ZQ, et al. Among authors: zeng zm. Thorac Cancer. 2021 Jan;12(2):172-180. doi: 10.1111/1759-7714.13738. Epub 2020 Nov 17. Thorac Cancer. 2021. PMID: 33205587 Free PMC article. Clinical Trial.

7

Two different patients with pulmonary pleomorphic carcinoma response to PD-1 inhibitor plus anlotinib.

Luo Y, Wei J, Zhang J, Zeng L, Zeng Z, Liu A. Luo Y, et al. Lung Cancer. 2021 May;155:170-174. doi: 10.1016/j.lungcan.2021.03.019. Epub 2021 Mar 26. Lung Cancer. 2021. PMID: 33838468 Free article.

8

Efficacy and acquired resistance for EGFR-TKI plus thoracic SBRT in patients with advanced EGFR-mutant non-small-cell lung cancer: a propensity-matched retrospective study.

Wang X, Zeng Z, Cai J, Xu P, Liang P, Luo Y, Liu A. Wang X, et al. BMC Cancer. 2021 Apr 30;21(1):482. doi: 10.1186/s12885-021-08228-2. BMC Cancer. 2021. PMID: 33931014 Free PMC article.

9

EGFR (p. G719A+L747V)/EML4-ALK Co-alterations in Lung Adenocarcinoma with Leptomeningeal Metastasis Responding to Afatinib Treatment: A Case Report.

Lu Z, Wang X, Luo Y, Wei J, Zeng Z, Xiong Q, Cai J, Liu A. Lu Z, et al. Onco Targets Ther. 2021 Apr 23;14:2823-2828. doi: 10.2147/OTT.S294635. eCollection 2021. Onco Targets Ther. 2021. PMID: 33935502 Free PMC article.

10

Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study.

Wang X, Cai J, Zeng Z, Liu A. Wang X, et al. BMC Cancer. 2021 Jul 30;21(1):873. doi: 10.1186/s12885-021-08581-2. BMC Cancer. 2021. PMID: 34330231 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters